The biggest winners of the Inflation Reduction Act

For the first time in history, Medicare has the power to negotiate drug prices. Granted, in the beginning, the number of drugs is limited to 10 of the most expensive single-source drugs; however, the number will increase. However, there are some caveats to the new law regarding which drugs Medicare negotiates the price. Which drugs and how hard will it be? Anajalee Khemlani discusses how Medicare is the biggest winner of the Inflation Reduction Act and how soon they will see the results. Read Ms. Khemlani’s article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org